Combination Osimertinib and Gefitinib in C 797 S

Combination Osimertinib and Gefitinib in C 797 S and T 790 M EGFR-Mutated Non–Small Cell Lung Cancer Surein Arulananda, M. B. B. S. , Hongdo Do, Ph. D, Ashan Musafer, MLab. Med, Paul Mitchell, MD, Alexander Dobrovic, Ph. D, Thomas John, M. B. B. S. , Ph. D Journal of Thoracic Oncology Volume 12 Issue 11 Pages 1728 -1732 (November 2017) DOI: 10. 1016/j. jtho. 2017. 08. 006 Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Journal of Thoracic Oncology 2017 121728 -1732 DOI: (10. 1016/j. jtho. 2017. 08. 006) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Figure 2 Journal of Thoracic Oncology 2017 121728 -1732 DOI: (10. 1016/j. jtho. 2017. 08. 006) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Figure 3 Journal of Thoracic Oncology 2017 121728 -1732 DOI: (10. 1016/j. jtho. 2017. 08. 006) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Figure 4 Journal of Thoracic Oncology 2017 121728 -1732 DOI: (10. 1016/j. jtho. 2017. 08. 006) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions